The good fight – the drug development pipeline with Jesper Brandgaard

 


Jesper Brandgaard, the CFO of leading diabetes care company Novo Nordisk.


Back to Feature Details


cachename:Featurescachekey:rd287061521_1727754622_rd221744618_1665871594_rd-1665407042_727740091_rd-488908060_1008847663_